Press Releases

Seattle, WA - Jan 30, 2012

Benaroya Research Institute Names Dr. Jane Buckner as Associate Director

Benaroya Research Institute at Virginia Mason (BRI) recently announced Jane Buckner, MD, as Associate Director, a position created to support the significant growth of the Institute in the last several years. Dr. Buckner will provide leadership support for the Kenneth R. Wilske Center for Translational Research at Virginia Mason and oversight of BRI Business Development and Core Laboratories. Additionally, Dr. Buckner is Program Director for Translational Research and a Principal Investigator at BRI.

Dr. Buckner joined BRI in 1999 and is internationally recognized for her research in understanding the immunologic and genetic causes of autoimmune diseases including Type 1 diabetes, multiple sclerosis (MS), rheumatoid arthritis, lupus and relapsing polychondritis. Dr. Buckner sees patients with rheumatic diseases at the Virginia Mason Clinic and at the University of Washington as a clinical associate professor of medicine.

About Benaroya Research Institute

Benaroya Research Institute (BRI) is a world leader in human immune system research. BRI works to advance the science that will predict, prevent, reverse and cure immune system diseases like allergies, asthma, cancer and autoimmune diseases. BRI accelerates discovery through laboratory breakthroughs in immunology that are then translated to clinical therapies. We believe that a breakthrough in one immune system disease can lead to progress against them all, and work tirelessly toward our vision of a healthy immune system for everyone. BRI is a world-renowned independent nonprofit research institute affiliated with Virginia Mason Franciscan Health and based in Seattle.

To learn more, visit benaroyaresearch.org and connect with us on Facebook, Instagram, Threads, LinkedIn, X and YouTube.